Stories

OHSU Cancer Institute Presents Findings From Phase 3 Multicenter Study Of Active Cellular Immunotheraphy In Early Stage Prostate Cancer Patients

June 04, 2007

Data from an ongoing study designed to explore the biologic and clinical activity of cancer immunotherapy sipuleucel-T, or Provenge, in patients with early stage recurrent prostate cancer who have a rising serum prostate specific antigen (PSA) level, ...

Druker Named OHSU Cancer Institute Director

May 21, 2007

Brian Druker, M.D., the world-renowned cancer specialist who helped develop the cancer pill Gleevec, which revolutionized the way cancer is treated, will be the new director of the Oregon Health & Science University Cancer Institute, it was announced ...

Druker Named OHSU Cancer Institute Director

May 21, 2007

Brian Druker, M.D., the world-renowned cancer specialist who helped develop the cancer pill Gleevec, which revolutionized the way cancer is treated, will be the new director of the Oregon Health & Science University Cancer Institute, it was announced ...

OHSU Cancer Institute Researcher,Physician To Meet With Legislators During 2007 LIVESTRONG Day

May 15, 2007

Oregon Health & Science University Cancer Institute’s Brandon Hayes-Lattin, M.D., will join the Lance Armstrong Foundation (LAF) in Washington, D.C., on Capitol Hill Wednesday, May 16, to demand that our nation’s leaders invest in resources, treatment ...

OHSU Cancer Institute Researcher,Physician To Meet With Legislators During 2007 LIVESTRONG Day

May 15, 2007

Oregon Health & Science University Cancer Institute’s Brandon Hayes-Lattin, M.D., will join the Lance Armstrong Foundation (LAF) in Washington, D.C., on Capitol Hill Wednesday, May 16, to demand that our nation’s leaders invest in resources, treatment ...

OHSU'S Cancer Institute Leukemia Leader Brian Druker Is Elected To National Academy Of Sciences

May 01, 2007

Brian Druker, M.D., leukemia program leader for the Oregon Health & Science University Cancer Institute, has been elected to the highly prestigious National Academy of Sciences. The National Academy of Sciences (NAS) is an honorific society of ...

OHSU'S Cancer Institute Leukemia Leader Brian Druker Is Elected To National Academy Of Sciences

May 01, 2007

Brian Druker, M.D., leukemia program leader for the Oregon Health & Science University Cancer Institute, has been elected to the highly prestigious National Academy of Sciences. The National Academy of Sciences (NAS) is an honorific society of ...

New Colorectal Cancer Clinic, Registry For High Risk Patients Open at OHSU

April 12, 2007

Christine Bennett-Hanes was 27 when she was diagnosed with colorectal cancer. "I didn't think it was really possible for me to have cancer. I was too young," said Bennett-Hanes, now 41, of southwest Portland, and the mother of 7-year-old twins, Zoe ...

New Colorectal Cancer Clinic, Registry For High Risk Patients Open at OHSU

April 12, 2007

Christine Bennett-Hanes was 27 when she was diagnosed with colorectal cancer. "I didn't think it was really possible for me to have cancer. I was too young," said Bennett-Hanes, now 41, of southwest Portland, and the mother of 7-year-old twins, Zoe ...

OHSU Cancer Institute Researcher Finds Computer Technology Does Not Improve Breast Cancer Detection

April 04, 2007

An Oregon Health & Science University Cancer Institute researcher is among a group of scientists who have found that the use of computer applications initially designed to improve the interpretation of mammography is less accurate than the standard ...

Stories

OHSU in the News